BioCentury
ARTICLE | Company News

Affinivax, PATH deal

February 23, 2015 8:00 AM UTC

Affinivax and PATH partnered to develop Affinivax’s vaccine candidate to prevent Streptococcus pneumoniae infections. The vaccine was developed using Affinivax’s multiple antigen presenting system (MA...